Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Aqdot emulsifies $7.8m series B
Cambridge-founded chemicals products maker Aqdot has welcomed the return of IP Group and Parkwalk Advisors in its latest round, taking its funding total to $16.5m.
TearSolutions eyes $6.4m
UVA’s seed fund and corporate venturing unit PharmStandard Ventures featured in topical dry eye syndrome peptide spinout TearSolutions' financing round, taking its total to $21.5m.
Agerris reaps $4.6m
Uniseed, Carthona Capital and BridgeLane Group provided the funding for University of Sydney-founded Agerris, which is preparing to commercialise products including robotic farm hand systems.
Hungry devours $8m
Catering services marketplace Hungry has now raised $12.5m in total, having added university venture unit James Madison Innovations to its investment consortium.
Mints chips in to $6m Movellus round
University of Michigan’s Mints vehicle joined existing investor Intel Capital for SOC producer Movellus’ series A round, which increased the company's overall funding to $10m.
NextGen Jane nets $9m in series A funding
NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.
Oxford Genetics locks in $8.5m
Founding investor Mercia Technologies joined fund manager Invesco for the synthetic biology contractor’s latest round, taking its total funding past the $25m mark.
Kyoto aligns itself with AlphaNavi's series A
Kyoto University has taken part in an $8.1m series A round for Alphanavi Pharma, which is developing drugs for neuropathic pain that will partly be based on the institution's research.

Other News

MoBagel moseys ahead with $5m
The series A funding comes after predictive data analytics companies MoBagel went through a resources-only edition of the SkyDeck accelerator last year.
NervGen Pharma holds nerve for $7.5m IPO
CWRU-licensed NervGen Pharma floated at the top of its range on the TSX Venture Exchange, with the proceeds earmarked to push its lead candidate for spinal cord injury into the clinic.
NemaMetrix clinches $5m
Oregon Venture Fund and Rogue Venture Partners have both backed University of Oregon's DNA testing services provider NemaMetrix to bring the spinout’s total to $8.5m.
Complion complies for $7m series B
Complion collected funding from investors including the multi-university-backed Ohio Innovation Fund for its regulatory compliance software platform catered to sites conducting clinical research.
OssDsign takes in $6.9m
Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.
Allied Minds prepares cost reductions
The commercialisation firm will cut cash operating expenses by more than 40% year-on-year, while SciFluor Life and Precision Biopsy received $9m in financing between them.

Editor's Picks

Manchester signs deal with IP Group
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
Dyson sucks up $7.9m for RCA start-ups
British investor Sir James Dyson, founder of vacuum cleaner company Dyson, is donating $7.9m to The Royal College of Art to support engineering start-ups.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
test reg